I too picked up some shares today. I don't know precisely when the approval will come, or what price we'll be at the close the day before, but I believe that when approval is announced we'll see the Mother of all Gaps, and it's a gap that never will be filled. If the share price doesn't improve dramatically between now and approval I certainly believe the gap could be to a market cap in the $2 to $3 billion range, perhaps even higher if substantial media attention surrounds the approval announcement.
Today it was pointed out to me that when a company receives news from the FDA they must release it within 4 days. I don't know if identically the same applies to the UK, but if it does, the question is, do you release immediately, or do you work with major media outlets to plan a release on a given day with stories flooding the press and the airways with information about the new paradigm for treating cancer. I frankly don't know if such a major PR campaign can be engineered in this way, but if it can be, I think it would be worth doing. If it were done, a gap that takes the market cap over $5 billion is very possible, and the share price by the end of the day could be close to $10 or possibly more.
Is a market cap over $10 billion justified on approval for the UK? Probably not based on UK revenue immediately, but undervalued if based on it's potential as a new paradigm in the treatment of many solid cancers. I have seen cures for mice take a company from $1 to over $100, but of course it came back down to earth and didn't ultimately work in people. I believe that the DCVax's will work in people because it's made from the people it's being used in. It won't necessarily be curative itself, but it will make existing, and new treatments work better, for some, that will be a cure, for others, a longer life. Perhaps as or more important, at least to some, it will add no negative side effects, and may be able to eliminate certain treatments that have some of the worst side effects. It will take years, perhaps even decades to learn all the best ways to use it. We all should know that aspirin has been around for over a century and they still find new uses rather routinely.
There are people suggesting that other diseases can be benefitted with NWBO's personalizing technology. I frankly don't know how. Sure, without a tumor it would be possible to make DCVax-Direct with leukapheresis, but what do you inject it into. As I understand Direct, it's effective because it's creating the vaccine when injected into the tumor. Where do you put it to fight other diseases, or blood borne cancers for that matter. I believe much can be done with personalized medicines, I just don't know that it can be done in the same manner in the EDEN unit.
Gary
